Diethylamine

Diethylamine

SCHEMBL1259556

CCNCC.O=c1c(O)c(-c2ccccc2)oc2ccc(CBr)cc12

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.59
▸ KDM4E B2RXH2 8/20 0.59
▸ CYP3A4 P08684 8/20 0.53
▸ MEN1 O00255 7/20 0.53
▸ KMT2A Q03164 7/20 0.53
▸ TP53 P04637 7/20 0.53
▸ ALOX15 P16050 3/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ ABCB1 P08183 1/20 0.53
▸ CALM1 P0DP23 1/20 0.53
▸ AR P10275 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ CYP1B1 Q16678 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ BCHE P06276 1/20 0.50
▸ ACHE P22303 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flavonol SCHEMBL28259264 0.83 KDM4E (0.78) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL1259555 0.80 MAPT (0.51) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL4650064 0.75 MAPT (1.00) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL15456750 0.75 CYP3A4 (0.82) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL1627936 0.75 CYP3A4 (0.82) MAPTKDM4ECYP3A4MEN1KMT2A
Flavonol SCHEMBL28173937 0.73 KDM4E (0.85) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL74701 0.73 CYP3A4 (0.74) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL5130608 0.72 MAPT (0.70) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL12941005 0.72 MKNK2 (0.75) MAPTKDM4ECYP3A4MEN1KMT2A
SCHEMBL6700894 0.72 KDM4E (0.70) MAPTKDM4ECYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948633-B1 3 -HYDROXYFLAVONE DERIVATIVES FOR THE DETECTION AND THE QUANTIFICATION OF CELL APOPTOSIS CENTRE NAT RECH SCIENT (FR) 2011-08-10 — — EP disclosed
US-7880021-B2 reacting 6-bromomethyl-4'-(diethylamino)-3-hydroxyflavone with dodecylmethylamine to form the corresponding tertiary amine (4'-(diethylamino)-6-(dodecyl(methyl)aminomethyl)-3-hydroxyflavone); and reacting the product of step a. with propansultone; use in biomembrane studies; Alzheimer's disease, cancer CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2011-02-01 — — US disclosed
US-20090269793-A1 Compounds and Kits for the Detection and the Quantification of Cell Apoptosis Centre National De La Recherche Scientifiique (CNRS) 2009-10-29 — — US disclosed
EP-1948633-A2 3 -HYDROXYFLAVONE DERIVATIVES FOR THE DETECTION AND THE QUANTIFICATION OF CELL APOPTOSIS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2008-07-30 — — EP disclosed
WO-2007057782-A2 3 -HYDROXYFLAVONE DERIVATIVES FOR THE DETECTION AND THE QUANTIFICATION OF CELL APOPTOSIS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2007-05-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090269793-A1 Compounds and Kits for the Detection and the Quantification of Cell Apoptosis BAX, CASP3, BCL2 MAPT 4847/4885KDM4E 3642/4885CYP3A4 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback